CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
WANG Wei, LIU Qing-Bin, JING Wei. Astragalus membranaceus improves therapeutic efficacy of asthmatic children by regulating the balance of Treg/Th17 cells[J]. Chinese Journal of Natural Medicines, 2019, 17(4): 252-263

Astragalus membranaceus improves therapeutic efficacy of asthmatic children by regulating the balance of Treg/Th17 cells

WANG Wei, LIU Qing-Bin, JING Wei
Department of Pediatric, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021, China
Abstract:
Astragalus membranaceus may be a potential therapy for childhood asthma but its driving mechanism remains elusive. The main components of A. membranaceus were identified by HPLC. The children with asthma remission were divided into two combination group (control group, the combination of budesonide and terbutaline) and A. membranaceus group (treatment group, the combination of budesonide, terbutaline and A. membranaceus). The therapeutic results were compared between two groups after 3-month therapy.Porcine peripheral blood mononuclear cells (PBMCs) were isolated from venous blood by using density gradient centrifugation on percoll. The levels of FoxP3, EGF-β, IL-17 and IL-23 from PBMCs and serum IgE were measured. The relative percentage of Treg/Th17 cells was determined using flow cytometry. The main components of A. membranaceus were calycosin-7-O-glucoside, isoquercitrin, ononin, calycosin, quercetin, genistein, kaempferol, isorhamnetin and formononetin, all of which may contribute to asthma therapy. Lung function was significantly improved in the treatment group when compared with a control group (P < 0.05). The efficacy in preventing the occurrence of childhood asthma was higher in the treatment group than the control group (P < 0.05).The levels of IgE, IL-17 and IL-23 were reduced significantly in the treatment group when compared with the control group, while the levels of FoxP3 and TGF-β were increased in the treatment group when compared with the control group (P < 0.05). A. membranaceus increased the percentage of Treg cells and reduced the percentage of Th17 cells. A. membranaceus is potential natural product for improving the therapeutic efficacy of combination therapy of budesonide and terbutaline for the children with asthma remission by modulating the balance of Treg/Th17 cells.
Key words:    Astragalus membranaceus    Asthma    Children    Treg/Th17    Budesonide    Terbutaline   
Received: 2018-12-28   Revised:
Tools
PDF (3737 KB) Free
Print this page
Email this article to others
Authors
Articles by WANG Wei
Articles by LIU Qing-Bin
Articles by JING Wei
References:
[1] Croisant S. Epidemiology of asthma:prevalence and bur-den of disease. Heterogeneity in Asthma[M]. Springer, 2014, 795:17-29.
[2] Huang SJ, Lin LL, Chen LC, et al. Prevalence of airway hyperresponsiveness and its seasonal variation in children with asthma[J]. Pediatr Neonatol, 2018, S1875-9572(17):30322-30324.
[3] Arikoglu T, Unlu A, Yildirim DD, et al. The airway hyperresponsiveness to methacholine may be predicted by impulse oscillometry and plethysmography in children with well-controlled asthma[J]. J Asthma, 2017, 12:1-8.
[4] Elias JA, Zhu Z, Chupp G, et al. Airway remodeling in asthma[J]. J Clin Invest, 1999, 104(8):1001-1006.
[5] Bønnelykke K, Sleiman P, Nielsen K, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations[J]. Nat Genet, 2014, 46(1):51-55.
[6] Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma:a randomized controlled trial[J]. Am J Respir Crit Care Med, 2001, 163(1):32-36.
[7] Samarasinghe RA, Witchell SF, DeFranco DB. Cooperativ-ity and complementarity:synergies in non-classical and classical glucocorticoid signaling[J]. Cell Cycle, 2012, 11(15):2819-2827.
[8] Ingemarsson I, Bengtsson B. A five-year experience with terbutaline for preterm labor:low rate of severe side effects[J]. Obstet Gynecol, 1985, 66(2):176-180.
[9] Del Bono N, Quartieri F, Vibelli C. Intravenous NAB 365(clenbuterol) and terbutaline in exercise-induced broncho-spasm (EIB)[J]. Clin Allergy, 1979, 9(3):277-282.
[10] Ahmad S, Kew KM, Normansell R. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids[J]. Cochrane Database Syst Rev, 2015, 19(6):CD011306.
[11] Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis:effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths[J]. Ann Intern Med, 2006, 144(12):904-912.
[12] Wu TJ, Wu CF, Lee YL, et al. Asthma incidence, remis-sion, relapse and persistence:a population-based study in southern Taiwan[J]. Respir Res, 2014, 15:135-143.
[13] To T, Gershon A, Wang C, et al. Persistence and remission in childhood asthma:a population-based asthma birth cohort study[J]. Arch Pediatr Adolesc Med, 2007, 161(12):1197-1204.
[14] Heeringa JJ, Rijvers L, Arends NJ, et al. IgE-expressing memory B cells and plasmablasts are increased in blood of children with asthma, food allergy and atopic dermatitis[J]. Allergy, 2018, 73(6):1331-1336.
[15] Ding F, Fu Z, Liu B. Lipopolysaccharide exposure allevi-ates asthma in mice by regulating Th1/Th2 and Treg/Th17 balance[J]. Med Sci Monit, 2018, 24:3220-3229.
[16] Lu X, Fu H, Han F, et al. Lipoxin A4 regulates PM2.5-induced severe allergic asthma in mice via the Th1/Th2 balance of group 2 innate lymphoid cells[J]. J Thorac Dis, 2018, 10(3):1449-1459.
[17] Barsheshet Y, Wildbaum G, Levy E, et al. CCR8(+)FOXp3(+) Treg cells as master drivers of immune regulation[J]. Proc Natl Acad Sci USA, 2017, 114(23):6086-6091.
[18] Huang F, Yin JN, Wang HB, et al. Association of imbal-ance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in children[J]. Allergy Asthma Proc, 2017, 38(6):70-77.
[19] Kalicki B, Wawrzyniak A, Lipinska-Opalka A, et al. In-fluence of Vitamin D and cotinine on T-Regulatory cells and asthma severity in children[J]. Adv Exp Med Biol, 2017, 1021:27-36.
[20] Liang P, Peng S, Zhang M, et al. Huai Qi Huang corrects the balance of Th1/Th2 and Treg/Th17 in an ovalbumin-induced asthma mouse model[J]. Biosci Rep, 2017, 37(6):1-8.
[21] Xu L, Li J, Zhang Y, et al. Regulatory effect of baicalin on the imbalance of Th17/Treg responses in mice with allergic asthma[J]. J Ethnopharmacol, 2017, 208:199-206.
[22] Nguyen KD, Vanichsarn C, Nadeau KC. TSLP directly impairs pulmonary Treg function:association with aberrant tolerogenic immunity in asthmatic airway[J]. Allergy Asthma Clin Immunol, 2010, 6(1):4-14.
[23] Wu X, Li X, Dang Z, et al. Berberine demonstrates anti-inflammatory properties in Helicobacter pylori-infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell-activating factor[J]. J Cell Biochem, 2018, 119(7):5373-5381.
[24] Kang Q, Zhang X, Liu S, et al. Correlation between the vitamin D levels and asthma attacks in children:Evaluation of the effects of combination therapy of atomization inhalation of budesonide, albuterol and vitamin D supplementation on asthmatic patients[J]. Exp Ther Med, 2018, 15(1):727-732.
[25] Pirozynski M, Hantulik P, Almgren-Rachtan A, et al. Evaluation of the efficiency of single-inhaler combination therapy with budesonide/formoterol fumarate in patients with bronchial asthma in daily clinical practice[J]. Adv Ther, 2017, 34(12):2648-2660.
[26] Politis A, Ioannidis V, Gourgoulianis KI, et al. Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia:A prospective, open-label, preference-based, 52-week, follow-up trial[J]. Chron Respir Dis, 2017, 15(2):146-156.
[27] Lin J, Zhou X, Wang C, et al. Symbicort(R) Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines[J]. Expert Rev Respir Med, 2018, 12(3):191-202.
[28] Rubin BK, Pohanka V. Beyond the guidelines:fatal and near-fatal asthma[J]. Paediatr Respir Rev, 2012, 13(2):106-111.
[29] Bian F, Wu YE, Zhang CL. Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis[J]. Exp Ther Med, 2017, 14(2):1621-1625.
[30] Schoon EJ, Bollani S, Mills PR, et al. Bone mineral den-sity in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease[J]. Clin Gastroenterol Hepatol, 2005, 3(2):113-121.
[31] Scalabrin DM, Sole D, Naspitz CK. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children:comparison of salbutamol, terbutaline, and fenoterol[J]. J Asthma, 1996, 33(6):407-415.
[32] Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)[J]. Phytother Res, 2014, 28(9):1275-1283.
[33] Che D, Adams S, Wei C, et al. Effects of Astragalus membranaceus fiber on growth performance, nutrient digestibility, microbial composition, VFA production, gut pH, and immunity of weaned pigs[J]. Microbiologyopen, 2018:e00712.
[34] Ma Y, Liu C, Qu D, et al. Antibacterial evaluation of sliver nanoparticles synthesized by polysaccharides from Astragalus membranaceus roots[J]. Biomed Pharmacother, 2017, 89:351-357.
[35] Peng T, Yang Y, Riesemann H, et al. The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication[J]. Chin Med Sci J, 1995, 10(3):146-150.
[36] Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis[J]. World J Gastroenterol, 2005, 11(37):5787-5794.
[37] Liu P, Zhao H, Luo Y. Anti-aging implications of Astraga-lus membranaceus (Huangqi):A well-known Chinese tonic[J]. Aging Dis, 2017, 8(6):868-886.
[38] Qin L, Tan HL, Wang YG, et al. Astragalus membranaceus and Salvia miltiorrhiza ameliorate lipopolysaccharide-induced acute lung injury in rats by regulating the toll-like receptor 4/nuclear factor-kappa B signaling pathway[J]. Evid Based Complement Alternat Med, 2018, 2018(1):1-10.
[39] Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention:GINA executive summary[J]. Eur Respir J, 2008, 31(1):143-178.
[40] Zhang L, Fu J, Sheng K, et al. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17[J]. Int Immunopharmacol, 2015, 25(1):96-105.
[41] Lapin B, Ownby D, Turyk M, et al. Relationship between in utero C-reactive protein levels and asthma in at-risk children[J]. Ann Allergy Asthma Immunol, 2015, 115(4):282-287.
[42] Tang W, Smith SG, Du W, et al. Interleukin-25 and eosi-nophils progenitor cell mobilization in allergic asthma[J]. Clin Transl Allergy, 2018, 8(5)1-9.
[43] Kostikas K, Brindicci C, Patalano F. Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD[J]. Curr Drug Targets, 2018, 19(16):1882-1896.
[44] Langley SJ, Goldthorpe S, Custovic A, et al. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients[J]. Ann Allergy Asthma Immunol, 2003, 91(4):398-404.
[45] Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES Ⅲ and ERS/GLI 12 for airway obstruction classification and severity[J]. Eur Respir J, 2016, 48(1):133-141.
[46] Cao YX, Dong JC, Du YJ. Biomarkers and inflammatory characteristics for microcosmic syndrome differentiation of cold-phlegm syndrome and heat-phlegm syndrome in patients with bronchial asthma[J]. Chin J Integr Tradit West Med, 2010, 30(8):828-832.
[47] Ko AR, Kim YH, Sol IS, et al. High-sensitivity C-reactive protein can reflect small airway obstruction in childhood asthma[J]. Yonsei Med J, 2016, 57(3):690-697.
[48] Omenaas E, Bakke P, Eide GE, et al. Total serum IgE and FEV1 by respiratory symptoms and obstructive lung disease in adults of a Norwegian community[J]. Clin Exp Allergy, 1995, 25(8):682-689.
[49] Wei Y, Luo QL, Sun J, et al. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model[J]. J Ethnopharmacol, 2015, 164:368-377.
[50] Jia Z, Wang X, Wang X, et al. Calycosin alleviates allergic contact dermatitis by repairing epithelial tight junctions via down-regulating HIF-1alpha[J]. J Cell Mol Med, 2018, 22(9):4507-4521.
[51] Clifton-Bligh PB, Nery ML, Clifton-Bligh RJ, et al. Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study[J]. Eur J Clin Nutr, 2015, 69(1):134-142.
[52] Barros LM, Duarte AE, Pansera Waczuk E, et al. Safety assessment and antioxidant activity of Lantana montevidensis leaves:Contribution to its phytochemical and pharmacological activity[J]. Excli J, 2017, 16:566-582.
[53] Kawai M, Hirano T, Arimitsu J, et al. Effect of enzymati-cally modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis:a randomized double-blind pla-cebo-controlled trial[J]. Int Arch Allergy Immunol, 2009, 149(4):359-368.
[54] Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category Ⅲ chronic prostatitis:a preliminary prospective, double-blind, placebo-controlled trial[J]. Urology, 1999, 54(6):960-963.
[55] Wang J, Wu J, Kong L, et al. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice[J]. J Ethnopharmacol, 2014, 154(1):131-147.
[56] Zhou X, Zhu J, Bian T, et al. Mislocalization of Runt-related transcription factor 3 results in airway inflammation and airway hyper-responsiveness in a murine asthma model[J]. Exp Ther Med, 2017, 14(3):2695-2701.
[57] Oliveira TT, Campos KM, Cerqueira-Lima AT, et al. Potential therapeutic effect of Allium cepa L. and quercetin in a murine model of Blomia tropicalis induced asthma[J]. Daru, 2015, 23(1):18-29.
[58] Zhu JX, Wen L, Zhong WJ, et al. Quercetin, kaempferol and isorhamnetin in Elaeagnus pungens Thunb. leaf:pharmacological activities and quantitative determination studies[J]. Chem Biodivers, 2018, 15(8):e1800129.
[59] Anderson D, Dhawan A, Yardley-Jones A, et al. Effect of antioxidant flavonoids and a food mutagen on lymphocytes of a thalassemia patient without chelation therapy in the Comet assay[J]. Teratog Carcinog Mutagen, 2001, 21(2):165-174.
[60] Shin D, Park SH, Choi YJ, et al. Dietary compound kaem-pferol inhibits airway thickening induced by allergic reaction in a bovine serum albumin-induced model of asthma[J]. Int J Mol Sci, 2015, 16(12):29980-29995.
[61] Li Y, Chi G, Shen B, et al. Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling[J]. Inflammation, 2016, 39(4):1291-1301.